ANTIBODIES, USES & METHODS

CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES

ANTI-MET ANTIBODIES AND USES THEREOF

METHODS OF USE OF ANTI-SORTILIN ANTIBODIES

SINGLE DOMAIN ANTIBODY AGAINST PD-L1 AND USE THEREOF

PANCREAS TARGETED THERAPEUTICS AND USES THEREOF

Antibodies binding to CD3 and CD19

VISTA REGULATORY T CELL MEDIATOR PROTEIN, VISTA BINDING AGENTS AND USE THEREOF

VEGFA-BINDING MOLECULES

METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES

PEPTIDES AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA

HER2/neu-Specific Antibodies and Methods of Using Same

COMPOSITIONS AND METHODS FOR TREATMENT OF RHEUMATOID ARTHRITIS AND ACCELERATED ATHEROSCLEROSIS

CHLAMYDIA VACCINE BASED ON TARGETING MOMP VS4 ANTIGEN TO ANTIGEN PRESENTING CELLS

ANTI-PSMA ANTIBODIES AND CAR-T STRUCTURES

LOW INTENSITY ULTRASOUND COMBINATION CANCER THERAPIES

Automated heart valve manufacturing

MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

HUMAN MONOCLONAL ANTIBODIES TO GANGLIOSIDE GD2

METHODS AND MATERIALS FOR TREATING CLONAL T CELL EXPANSIONS

ANTI-PSGL-1 ANTIBODIES AND USES THEREOF

METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS

Compositions and methods of treating facioscapulohumeral muscular dystrophy

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

ANTIBODIES TO IGF2R AND METHODS

FC RECEPTOR BINDING PROTEINS

Antibodies Specific for CD47, PD-L1, and Uses Thereof

NOVEL BISPECIFIC POLYPEPTIDE COMPLEXES

IGM FC AND J-CHAIN MUTATIONS THAT AFFECT IGM SERUM HALF-LIFE

LAG-3-Binding Molecules and Methods of Use Thereof

ANTIBODY MOLECULES FOR CANCER TREATMENT

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST TIGIT

KIR3DL2 BINDING AGENTS

COMBINATION THERAPIES FOR TREATING MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

Use of Anti-Il-6 Antibody, e.g., Clazakizumab for Desensitization of Solid Organ Transplant Recipients and/or for Preventing, Stabilizing or Reducing Antibody Mediated Rejection (ABMR)

INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING

INFLAMMASOME ANTIBODY COMPOSITON AND METHOD FOR TREATING NEUROLOGIC DISORDER

CHEMERIN INHIBITORS AND USES THEREOF FOR TREATING KIDNEY CANCER

EPITOPE PEPTIDE AND ANTIBODY FOR PREVENTING AND TREATING EB VIRUS INFECTION AND RELATED DISEASES

Use of a VEGF antagonist to treat angiogenic eye disorders

IMMUNOSTIMULATORY BACTERIA FOR THE TREATMENT OF CANCER

RETROVIRAL VECTOR FOR UNIVERAL RECEPTOR THERAPY

COMBINATION OF TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND A PD-1 AND/OR PD-L1 INHIBITOR, FOR USE AS A MEDICAMENT

METHODS OF TREATING NEOPLASTIC ASTROCYTOMA

CONDITIONALLY ACTIVE ANTI-EPCAM ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF

THERAPEUTIC ANTIGEN-BINDING MOLECULE WITH A FcRn-BINDING DOMAIN THAT PROMOTES ANTIGEN CLEARANCE

EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III ANTIBODIES

ANTIBODIES THAT BIND TO AXL PROTEINS

BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP

HEAVY CHAIN ANTIBODIES BINDING TO CD22

MULTISPECIFIC ANTIBODIES AND USES THEREOF

Bispecific anti-CCL2 antibodies

COMPOSITIONS AND METHODS FOR INCREASING MUSCLE MASS AND MUSCLE STRENGTH BY SPECIFICALLY ANTAGONIZING GDF8 AND OR ACTIVIN A

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G

METHOD

MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

Methods and composition for neutralization of influenza

Methods and composition for neutralization of influenza

Methods and composition for neutralization of influenza

Methods and composition for neutralization of influenza

Anti-EGFR Antibody-Drug Conjugates

ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE

METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA

CANCER TREATMENT COMBINATIONS

CANCER THERAPY

EFFECTIVE AND EFFICIENT CONTROL OF SERUM PHOSPHATE FOR OPTIMAL BONE FORMATION

USE OF CLOSTRIDIUM GHONII SPORE COMBINED WITH PEMBROLIZUMAB

CHIMERIC ANTIGEN AND T CELL RECEPTORS AND METHODS OF USE

HTR1F ANTAGONISTS FOR IMPROVEMENT OF BETA CELL SURVIVAL AND FUNCTION

METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS

ANTI-CD38 ANTIBODIES AND THEIR USES

BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERS

ANTIBODY AND TAXANE COMBINATION THERAPY

CCR6 ANTIBODIES

TREATMENT OF CHRONIC PRURIGO

ANTI-IL-9 ANTIBODIES AND METHODS OF USE THEREOF

NOVEL SLOW-RELEASE PRODRUGS

Compositions and Methods for Treating Cancer with Anti-CD22 Immunotherapy

COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 IN COMBINATION WITH IMMUNE CHECK-POINT PATHWAY INHIBITORS

METHODS OF PRODUCING MIXED CHIMERISM AFTER A SOLID ORGAN TRANSPLANT

KRAS G12C INHIBITOR DOSING REGIMENS

PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT

ANTIBODIES TO TICAGRELOR AND METHODS OF USE

A METHOD OF PREVENTING, ALLEVIATING OR TREATING A TUMOR

BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47

ANTIBODIES FOR TREATMENT OF CANCER EXPRESSING CLAUDIN 6

MONOCLONAL ANTIBODY NEO-201 FOR THE TREATMENT OF HUMAN CARCINOMAS

MODULATION OF CD46 CELL SURFACE EXPRESSION AND THERAPEUTIC USE THEREOF

FORMULATIONS OF ANTI-CD73 ANTIBODIES

METHODS OF TREATING CANCERS AND ENHANCING EFFICACY OF T CELL REDIRECTING THERAPEUTICS

ANTI-APRIL ANTIBODIES AND USES THEREOF

ANTI-TRKB ANTIBODIES

ANTI-MET ANTIBODIES AND USES THEREOF

ANTI-FGFR3 ANTIBODY AND USE THEREOF

BISPECIFIC ANTIBODIES COMPRISING AN NRP1 BINDING DOMAIN AND METHODS OF USE THEREOF

METHODS OF USE OF ANTI-SORTILIN ANTIBODIES

BINDING AGENTS AND METHODS OF USING THE SAME

METHOD AND COMPOSITION FOR INDUCING TOLERANCE

ANTI-HUMAN LAIR1 ANTIBODIES

METHODS FOR IDENTIFYING LILRB-BLOCKING ANTIBODIES

TREATMENT OF PERITONEAL, PLEURAL, AND PERICARDIUM ADHESIONS

METHOD FOR INHIBITING TUMOUR CELL GROWTH BASED ON CCDC112

Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody

OSTEOPONTIN MONOCLONAL ANTIBODIES FOR CANCER AND OSTEOPOROSIS IMMUNOTHERAPY

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

Novel Angiopoietin 2, VEGF Dual Antagonists

ANTI-CfaE ANTIBODIES AND METHODS OF USE

SARBECOVIRUS BINDERS

MONOCLONAL ANTIBODIES AGAINST CORONAVIRUSES AND USES THEREOF

MESOTHELIN BINDING PROTEINS

METHODS AND COMPOSITIONS FOR ENHANCING THE POTENCY OF SUPERANTIGEN MEDIATED CANCER IMMUNOTHERAPY

Serum Albumin-Binding Fibronectin Type III Domains

OFF-THE-SHELF iPSC-DERIVED NK CELL THERAPY FOR HEMATOLOGICAL CANCER TREATMENT

COMBINATION THERAPY OF PD-1 AXIS BINDING ANTAGONISTS AND LRRK2 INHITIBORS

Anti-Tumor Immunotherapy Enhancer

COMPOSITIONS FOR INHIBITING MASP-2 DEPENDENT COMPLEMENT ACTIVATION

HER3 ANTIGEN-BINDING MOLECULES

METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB IN COMBINATION WITH CAPECITABINE AND TRASTUZUMAB

ANTIBODIES TARGETING TROP2 AND CD3 AND USES THEREOF

ANTI-HUMAN TROP-2 ANTIBODY AND APPLICATION THEREOF

CD38 MODULATING ANTIBODY

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

ANTI-CD30L ANTIBODIES AND USES THEREOF

ANTIBODY MOLECULES TO APRIL AND USES THEREOF

T CELL RECRUITING POLYPEPTIDES BASED ON TCR ALPHA/BETA REACTIVITY

Anti-CCR7 antibody drug conjugates

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES

Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof

ANTI-SIGLEC-15 ANTIBODY AND APPLICATION THEREOF IN PREPARING DRUG

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

ANTIBODY FUSION PROTEIN AND RELATED COMPOSITIONS FOR TARGETING CANCER

Engineered anti-IL-2 antibodies

ANTI-INTERLEUKIN-33 ANTIBODIES AND USES THEREOF

MODULATING INTERLEUKIN-10 SIGNALING TO BOOST HEALING IN DIABETIC WOUNDS

ANTI-ANGPTL3 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND PREPARATION METHOD AND USE THEREOF

METHODS OF TREATING COMPLEMENT MEDIATED THROMBOTIC MICROANGIOPATHY USING AN ANTI-C5 ANTIBODY

COMPOSITION OF HUMAN RECOMBINANT ANTIBODY FRAGMENTS THAT COMPLETELY NEUTRALIZE THE VENOM OF THE SCORPION CENTRUROIDES SCULPTURATUS

METHODS AND COMPOSITIONS FOR PERTUSSIS DIAGNOSIS

BROADLY NEUTRALIZING ANTIBODIES AGAINST INFLUENZA NEURAMINIDASE

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B VIRUS INFECTION

CANCER COMBINATION TREATMENTS USING ANTI-STAT3 NUCLEIC ACID CONJUGATES

ANTIBODIES BINDING AXL

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

MODULATING INSULIN EXPRESSION AND PRODUCTION BY TARGETING CD47

USE OF TRANS-[TETRACHLOROBIS(1H-INDAZOLE)RUTHENATE(III)] FOR THE TREATMENT OF CANCER

METHODS OF USING MESOTHELIN

AN AGR2Xcd3 BISPECIFIC ENGAGER FOR THE TREATMENT OF CANCER

PERIPHERAL BLOOD PHENOTYPE LINKED TO OUTCOMES AFTER IMMUNOTHERAPY TREATMENT

Treatment Of Endometriosis With R-Spondin 3 (RSPO3) Inhibitors

METHODS OF TREATING AN EYE DISORDER

Protein S antibodies, methods of making and uses thereof

PROTEIN BIOMARKER AND USES THEREOF

MONOCLONAL ANTIBODIES AGAINST C-MET

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

ANTI-CUB DOMAIN-CONTAINING PROTEIN 1 (CDCP1) ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE THEREOF

VARIANT TARGET BINDING AGENTS AND USES THEREOF

ANTIBODIES BINDING CD40 AND PD-L1 AND USES THEREOF

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

GLUCAGON RECEPTOR BINDING PROTEINS AND METHODS OF USE THEREOF

INHIBITOR OF FIBROSIS PROGRESSION

Anti-Chemokin Like Receptor 1 Humanized Antibodies and Their Therapeutic Applications

MONOCLONAL ANTIBODY AGAINST HUMAN MAC-1 AND USES THEREOF

Use of Combination of Anti-PD-1 Antibody and VEGFR Inhibitor in Preparation of Drug for Treating Cancers

ANTI-PD-1/CD47 BISPECIFIC ANTIBODY AND USE THEREOF

BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47

Anti-MARCO Antibodies and Uses Thereof

VHH POLYPEPTIDES THAT BIND TO INTERLEUKIN 6 (IL-6), COMPOSITIONS AND METHODS OF USE THEREOF

PREVENTION AND TREATMENT OF STEROID-RESISTANT OR GUT GRAFT-VERSUS-HOST DISEASE (GVHD)

Methods of Using IL-1beta Compounds

COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES

BISPECIFIC ANTI-CCL2 ANTIBODIES

METHODS AND COMPOSITIONS FOR PRETARGETED IMMUNOTHERAPY

ANTI-BMP9 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF

HUMAN ANTIBODIES TO BET V 1 AND METHODS OF USE THEREOF

T-cell modulatory multimeric polypeptides and methods of use thereof

PROTEIN-POLYMER DRUG CONJUGATES

ANTI-PVRIG ANTIBODIES FORMULATIONS AND USES THEREOF

METHODS OF TREATING CANCER USING TIGIT INHIBITORS AND ANTI-CANCER AGENTS

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Methods for Enhancing Efficacy of a Vaccine by Administering an IL-4R Antagonist

GROWTH HORMONE ANTAGONIST AND ANTI-CANCER COMPOSITION COMBINATION THERAPY

METHODS FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST

METHOD OF DIAGNOSING AND TREATING NONALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS

FC-ENGINEERED ANTI-HUMAN IGE ANTIBODIES AND METHODS OF USE

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

METHODS AND COMPOSITIONS RELATING TO BISPECIFIC ANTI-CHI3L1 ANTIBODY REAGENTS

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER

Antibody molecules to C5AR1 and uses thereof

BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-GITR ANTIBODIES AND USES THEREOF

ANTI-CD137 CONSTRUCTS AND USES THEREOF

ANTI-CD123 BINDING MOLECULES AND USES THEREOF

HUMAN CCR8 BINDERS

ANTIBODIES THAT BIND TO AXL PROTEINS

AXL-SPECIFIC ANTIBODIES AND USES THEREOF

FGFR1 AGONISTS AND METHODS OF USE

ANTI-FLT-1 ANTIBODIES FOR TREATING DUCHENNE MUSCULAR DYSTROPHY

ANTI-E-SELECTIN ANTIBODIES, COMPOSITIONS AND METHODS OF USE

CD1a ANTIBODIES AND USES THEREOF

Antibodies to programmed cell death protein 1

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

APPROVED PRODUCTS FOR THE TREATMENT OF MULTIPLE MYELOMA

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, AND JOINT AND TENDON DISORDERS

ANTI-STEM CELL FACTOR ANTIBODIES AND METHODS OF BLOCKING THE INTERACTION BETWEEN SCF AND c-KIT

GREMLIN-1 CRYSTAL STRUCTURE AND INHIBITORY ANTIBODY

CONNECTIVE TISSUE GROWTH FACTOR ANTIBODIES

ANTI-MS4A4A ANTIBODIES AND METHODS OF USE THEREOF

ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE

NEUTRALIZING ANTI-INFLUENZA B ANTIBODIES AND USES THEREOF

T-cell modulatory multimeric polypeptides and methods of use thereof

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

FGF21 Mutants and Uses Thereof

Vaccines targeting Pseudomonas aeruginosa

Immunoconjugates and methods

CONJUGATES OF TUMOR NECROSIS FACTOR INHIBITORS TO FUNCTIONALIZED POLYMERS

ANTI-TIGIT ANTIBODIES, ANTI-PVRIG ANTIBODIES AND COMBINATIONS THEREOF

COMBINATION THERAPIES

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODY

TREATMENT OF CANCERS AND INFECTIOUS DISEASES WITH KILLED INTACT BACTERIA

METHODS FOR TREATING AND MONITORING FRONTOTEMPORAL DEMENTIA

VIRAL DELIVERY OF NEOANTIGENS

ANTI-FENTANYL ANTIBODIES

FACTOR XI ANTIBODIES AND METHODS OF USE

ANTIBODIES BINDING TO GPRC5D

CD73-BINDING PROTEIN AND USE THEREOF

ANTI-4-1BB ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

ANTIBODIES TO TNFR2 AND USES THEREOF

Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs)

FELINE ANTIBODY VARIANTS

ANTI-PD-L1 ANTIBODIES AND FUSION PROTEINS THEREOF

BISPECIFIC ANTIBODY AND USE THEREOF

MONOCLONAL ANTIBODY AGAINST HUMAN LAG-3, METHOD FOR PREPARING SAME, AND USE THEREOF

ANTI-SIGLEC-9 ANTIBODIES AND METHODS OF USE THEREOF

IMMUNE CHECKPOINTS

ANTI-TIGIT ANTIBODY PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

ANTIBODIES WITH IMPROVED STABILITY TO INTESTINAL DIGESTION, POLYNUCLEOTIDES THEREOF AND METHODS OF USE THEREOF TO TREAT DISEASE

Compositions and methods for treatment of chronic lung diseases

ANTIBODIES TO HUMAN GDF8

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

ANTI-TAU ANTIBODIES AND METHODS OF USE

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy

Muscle targeting complexes and uses thereof for treating dystrophinopathies

ANTI-CD47 ANTIBODIES AND USES THEREOF

EP4 INHIBITORS AND USE THEREOF

HERV-K Antibody Therapeutics

ANTI-OX40 ANTAGONISTIC ANTIBODIES AND DOSAGE FOR THE TREATMENT OF OX40-MEDIATED DISORDERS

METHODS OF INDUCING IMMUNE TOLERANCE WITH MODIFIED ANTI-CD154 ANTIBODIES

COMBINATION THERAPY FOR CANCERS WITH BRAF MUTATION

ANTI-CTLA-4 ANTIBODY AND USE THEREOF

SIALIDASE-PD-1-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

ANTI-CLDN-18.2 ANTIBODY AND USE THEREOF

TREATMENT OF DRY EYE SYNDROME USING AN OPHTHALMIC COMPOSITION COMPRISING TANFANERCEPT

ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF

RESPIRATORY SYNCYTIAL VIRUS-SPECIFIC BINDING MOLECULE

THERAPEUTIC ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST SARS-COV-2 GLYCOPROTEIN S

ANTIBODIES AGAINST SARS-COV-2 AND METHODS OF USING THE SAME

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

Dual cytokine fusion proteins comprising IL-10

USE OF FUSION CONSTRUCTS FOR IL-2 INDEPENDENT T CELL THERAPY

METHOD OF INDUCTION OF TUMOR ASSOCIATED ANTIGENS WITH BRYOSTATIN

Animal Models and Therapeutic Molecules

Binding Proteins 2

METHODS AND COMPOSITIONS FOR POTENTIATING ANTITUMORAL IMMUNE RESPONSES THROUGH TARGETING OF NTPDASE3

PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII

Targeting Intracellular Target-Binding Determinants with Intracellular Antibodies

Targeting Intracellular Target-Binding Determinants with Intracellular Antibodies

ANTI- IL27R ANTIBODIES AND METHODS OF USE THEREOF

NON-BLOCKING HUMAN CCR8 BINDERS

Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs

Sialylated Glycoproteins

Modified anti-PD-L1 Antibody and Methods and Uses for Treating a Neurodegenerative Disease

ANTI-PD-L1/ANTI-CD47 NATURAL ANTIBODY STRUCTURE-LIKE HETERODIMERIC FORM BISPECIFIC ANTIBODY AND PREPARATION THEREOF

MULTI-PARATOPIC ANTI-PD-1 ANTIBODIES AND USES THEREOF

RECOMBINANT CD3 BINDING PROTEINS AND THEIR USE

NOVEL FORMULATIONS FOR ANTIBODIES

ENHANCEMENT OF ANTI-TUMOR PHAGOCYTOSIS

METHODS FOR TREATING OCULAR DISEASES

DOSING REGIMEN FOR GP100-SPECIFIC TCR - ANTI-CD3 SCFV FUSION PROTEIN

IN VIVO METHODS FOR SELECTING PEPTIDES THAT CROSS THE BLOOD BRAIN BARRIER, RELATED COMPOSITIONS AND METHODS OF USE

Combination Treatment of Cancer

MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS